We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600111:SSEChina Northern Rare Earth (Group) High-Tech Co., Ltd. Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥50.82

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its 20‑day simple moving average while still above the 200‑day level, indicating a short‑term pull‑back within a longer‑term uptrend. RSI sits in the low‑40s, suggesting neutral momentum, but the MACD histogram is deeply negative and the signal line is bearish, reinforcing downside pressure. Volume has been trending down, and the price is approaching the identified support around 46.7 CNY, while the next resistance sits near 63.6 CNY. Beta is very low (≈0.22), meaning the stock moves less than the market, yet recent 30‑day volatility exceeds 70%, reflecting sharp price swings.
Fundamentally, revenue has surged 33% year‑over‑year, but margins remain thin (gross ~11%, operating ~9%). The company carries a high debt load (debt‑to‑equity ≈30) and a trailing P/E of 86, far above peers, while the discounted cash‑flow model implies a fair value near 2.3 CNY – a stark contrast to the current price of ~50 CNY. Dividend yield is modest at 0.07% with a low payout ratio, indicating sustainability, but the valuation gap suggests the stock is significantly overvalued despite growth prospects.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and negative histogram
  • Price near technical support with decreasing volume
  • Extreme overvaluation relative to DCF

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth but thin margins
  • High debt level limiting financial flexibility
  • Low beta but elevated price volatility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic importance of rare‑earth supply chain
  • Potential for margin improvement with scale
  • Persistent valuation disconnect and leverage concerns

Key Metrics & Analysis

Financial Health

Revenue Growth33.30%
Profit Margin5.13%
P/E Ratio86.1
ROE9.99%
ROA4.53%
Debt/Equity29.48
P/B Ratio7.7
Op. Cash FlowCN¥2.2B
Free Cash FlowCN¥274.5M

Technical Analysis

TrendBullish
RSI42.6
SupportCN¥46.69
ResistanceCN¥63.57
MA 20CN¥55.39
MA 50CN¥51.87
MA 200CN¥43.24
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥2.33
GradeOvervalued
TypeGrowth
Dividend Yield0.07%

Risk Assessment

Beta0.22
Volatility73.24%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.